I-MOVE COVID-19: European primary care and hospital network

The I-MOVE-COVID-19 consortium aims to obtain epidemiological and clinical information on patients with COVID-19 as well as virological information on SARS-CoV-2, through (a) provision of a flexible surveillance platform (adaptable to the epidemiological situation), (b) research studies and (c) evaluation of public health interventions (e.g. vaccination, antivirals). This project aims to contribute to the knowledge base, guide patient management, and inform the public health response. This will be achieved through adaptation and expansion of the existing, long-running, Europe-wide influenza surveillance network (I-MOVE) to include COVID-19. The network includes primary care networks, hospitals, and national laboratory reference centres in 10 countries across the WHO European Region. 

The I-MOVE-COVID-19 priority activities and research projects will be selected based on ECDC/WHO input and the proposal’s detailed list. These will be conducted by mobilising an existing large European multidisciplinary network, combining the expertise and resources of groups working in surveillance (epidemiological, clinical, virological), respiratory disease research, and evaluation of vaccines/treatments. Through protocol sharing and pooling of European results, research questions will be answered which could not be efficiently answered by countries acting alone. The I-MOVE-COVID-19 project will share study results rapidly and widely and contribute to the clinical management of patients, public health preparedness and response to COVID-19. 

Relevant Links

Keywords

COVID-19, SARS-CoV-2, epidemiology, virology, clinical presentation and severity

Associated Users

Location

Portugal: Instituto Nacional de Saúde Dr. Ricardo Jorge and Direção Geral da Saúde.

Entities

Instituto Nacional de Saúde Dr. Ricardo Jorge and Direção Geral da Saúde.

Epiconcept, France (coordinators) 

Public health Institute Albania 

Public Health England 

University of Oxford/RCGP RSC, UK 

Université Sorbonne, France 

Institut Pasteur, France 

Santé Publique France 

Université de Corse Pascal Paoli, France 

Vienna Vaccine Safety Initiative (ViVI), Germany 

HPSC, Ireland 

Lithuanian University of Health Sciences, Lithuania 

NIVEL, The Netherlands 

RIVM, The Netherlands 

INS Ricardo Jorge, Portugal 

DGS Portugal 

INCDMIC Cantacuzino, Romania 

Public Health Scotland 

ISCIII National Centre for Epidemiology, Spain 

ISCIII National Centre for Microbiology, Spain 

ISPL-Navarra, Spain 

Public Health Agency, Sweden 

0 Comments

Submit a Comment